Method for diagnosis and treatment of pulmonary disorders
    3.
    发明申请
    Method for diagnosis and treatment of pulmonary disorders 有权
    诊断和治疗肺功能障碍的方法

    公开(公告)号:US20050130928A1

    公开(公告)日:2005-06-16

    申请号:US10988486

    申请日:2004-11-12

    摘要: This invention relates to the discovery that midkine modulates pulmonary vasculature development and smooth muscle cell development. Modulation of midkine activity thus alters pulmonary vasculature development and smooth muscle cell development. The invention provides methods of modulating pulmonary disorders, smooth muscle cell related disorders, and pulmonary smooth muscle cell disorders. Disorders of particular interest include, but are not limited to, asthma and pulmonary hyperplasia. Further the invention relates to the discovery that TTF1 and HIF1 -α exhibit midkine modulating activity. The invention pertains to the discovery that midkine modulates myocardin activity.

    摘要翻译: 本发明涉及中期因子调节肺血管发育和平滑肌细胞发育的发现。 因此调节中期因子活性改变肺血管发育和平滑肌细胞发育。 本发明提供调节肺病,平滑肌细胞相关病症和肺平滑肌细胞病症的方法。 特别感兴趣的疾病包括但不限于哮喘和肺部增生。 此外,本发明涉及TTF1和HIF1-α显示中期因子调节活性的发现。 本发明涉及中期因子调节心肌素活性的发现。

    Method of screening a midkine modulating agent
    5.
    发明授权
    Method of screening a midkine modulating agent 有权
    筛选中期因子调节剂的方法

    公开(公告)号:US07951532B2

    公开(公告)日:2011-05-31

    申请号:US10988486

    申请日:2004-11-12

    IPC分类号: C12Q1/68 C12Q1/66 C12N15/67

    摘要: This invention relates to the discovery that midkine modulates pulmonary vasculature development and smooth muscle cell development. Modulation of midkine activity thus alters pulmonary vasculature development and smooth muscle cell development. The invention provides methods of modulating pulmonary disorders, smooth muscle cell related disorders, and pulmonary smooth muscle cell disorders. Disorders of particular interest include, but are not limited to, asthma and pulmonary hyperplasia. Further the invention relates to the discovery that TTF1 and HIF1 -α exhibit midkine modulating activity. The invention pertains to the discovery that midkine modulates myocardin activity.

    摘要翻译: 本发明涉及中期因子调节肺血管发育和平滑肌细胞发育的发现。 因此调节中期因子活性改变肺血管发育和平滑肌细胞发育。 本发明提供调节肺病,平滑肌细胞相关病症和肺平滑肌细胞病症的方法。 特别感兴趣的疾病包括但不限于哮喘和肺部增生。 此外,本发明涉及TTF1和HIF1-α显示中期因子调节活性的发现。 本发明涉及中期因子调节心肌素活性的发现。